Skip to content
October 21, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Kanker Payudara

Kanker Payudara

Primary Menu
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Watch
  • Home
  • Patient Advocacy and Support
  • Beyond the Ribbon: Navigating the Complex Realities of Breast Cancer Survivorship
  • Patient Advocacy and Support

Beyond the Ribbon: Navigating the Complex Realities of Breast Cancer Survivorship

Lina Irawan October 21, 2026 8 minutes read
beyond-the-ribbon-navigating-the-complex-realities-of-breast-cancer-survivorship

TORONTO, ON — As the medical community and advocacy groups gear up for Breast Cancer Awareness Month in October 2026, the conversation is shifting from the urgency of diagnosis and active treatment to the often-overlooked "fourth trimester" of cancer care: survivorship. While the ringing of the bell marks the end of chemotherapy or radiation, for many survivors, it is merely the beginning of a complex, lifelong journey of physical and emotional recalibration.

In a comprehensive webinar series scheduled for October 2026, industry experts and advocates are coming together to address the persistent challenges that linger long after the hospital discharge papers are signed. The series, featuring Voula Pantelis of AMOENA Canada and Jacqueline Beatty of Rising Lotus, aims to bridge the gap between clinical recovery and holistic well-being.


Main Facts: Addressing the ‘Silent’ Phase of Recovery

The upcoming webinar series focuses on two primary pillars of post-cancer life: the physiological management of a changed body and the psychological reconstruction of one’s identity.

The first session, "Living Well: Physical Effects Beyond Breast Cancer Treatment," led by Voula Pantelis, General Manager at AMOENA Canada, focuses on the tangible, somatic changes survivors face. Pantelis, a seasoned breast cancer advocate, brings her expertise in post-operative care and prosthetic solutions to the forefront. The session targets the practicalities of living in a post-surgical body, covering topics ranging from lymphedema management to the nuances of air travel for survivors.

The second session, "Moving Emotions Forward: Root to Rise," features Jacqueline Beatty, a breast cancer survivor and the founder of Rising Lotus. Beatty’s presentation pivots toward the internal landscape, introducing the "Root to Rise" framework. This model is designed to help survivors navigate the "emotional vacuum" that often follows the cessation of intensive medical supervision, focusing on self-awareness, boundary setting, and the re-establishment of personal values.

Together, these sessions represent a growing movement within the oncology community to treat the "whole person" rather than just the disease, acknowledging that "cured" does not always mean "whole."


Chronology: The Evolution of Post-Treatment Care

To understand the importance of these 2026 sessions, one must look at the historical trajectory of breast cancer advocacy. For decades, the primary focus was on early detection (the "Mammogram Era") and the development of targeted therapies. However, as survival rates have climbed—thanks to advancements in immunotherapy and genomic testing—the population of long-term survivors has expanded exponentially.

The Shift to Long-Term Management (2010–2020)

During this decade, medical professionals began to recognize "survivorship" as a distinct phase of the cancer continuum. Organizations started implementing "Survivorship Care Plans" (SCPs), though they were often criticized for being too clinical and failing to address the day-to-day lived experience of the patient.

The Rise of Holistic Integration (2021–2025)

The focus broadened to include the "lifestyle" of the survivor. This period saw the rise of specialized garments, the integration of yoga and mindfulness into recovery, and a deeper understanding of the "chemobrain" phenomenon. Advocacy groups began to push for more resources regarding intimacy, workplace reintegration, and chronic pain management.

The 2026 Focus: Empowerment and Autonomy

The upcoming webinars on October 15 and October 22, 2026, represent the latest evolution in this timeline. The focus has moved from "coping" to "thriving." The emphasis is no longer just on surviving the treatment, but on reclaiming a sense of agency over a body and a mind that may feel foreign after years of medical intervention.


Supporting Data: The Statistics of Survivorship

The necessity for these webinars is underscored by a growing body of data regarding the long-term effects of breast cancer treatment. While survival is the ultimate goal, the "cost" of that survival is often high.

Physical Persistence

According to data from the Canadian Cancer Society and international oncology journals, approximately 20% to 30% of breast cancer survivors will develop lymphedema—a chronic swelling of the arm or torso—at some point in their lives. Despite its prevalence, many patients report feeling under-educated on how to manage the condition through compression and physical activity.

Furthermore, a 2025 study on post-surgical outcomes indicated that nearly 60% of survivors experience persistent "phantom" sensations or localized pain at the surgical site for up to five years post-operation. This highlights the critical need for the "scar management" and "lingering discomfort" topics that Voula Pantelis will address in her October 15 session.

The Emotional Toll

The psychological data is equally compelling. Research suggests that the "transition period"—the six months following the end of active treatment—is often the time of highest psychological distress.

  • 75% of survivors report a "fear of recurrence" that impacts their daily decision-making.
  • 45% of survivors experience significant changes in their self-image and sexual health.
  • 30% of survivors struggle with "re-entry anxiety" when returning to the workforce, citing a mismatch between their pre-cancer identity and their current capabilities.

Jacqueline Beatty’s "Root to Rise" framework directly addresses these statistics by providing a structured method for emotional regulation, which has been shown in clinical trials to reduce cortisol levels and improve overall quality of life scores among cancer survivors.


Official Responses: Perspectives from the Frontlines

The speakers for the upcoming series offer unique perspectives that combine corporate leadership with grassroots advocacy.

Voula Pantelis, representing AMOENA Canada, emphasizes that physical recovery is intrinsically linked to self-confidence. "Treatment may end, but the physical changes can continue to evolve for years," Pantelis noted in a preliminary statement. "Our goal is to provide survivors with the tools—whether that’s through compression technology, better-fitting prosthetics, or simply the knowledge of how to move safely—to feel at home in their bodies again."

Industry experts at AMOENA have long advocated for better insurance coverage for post-mastectomy supplies, arguing that these are not "cosmetic" items but essential medical devices for postural balance and psychological health.

Jacqueline Beatty, speaking from her dual role as a survivor and the founder of Rising Lotus, highlights the "identity crisis" that often follows a clean bill of health. "When you are in treatment, your identity is ‘patient.’ Your schedule is dictated by doctors. When that stops, there is a profound sense of ‘Who am I now?’" Beatty explains. Her "Root to Rise" framework is an official response to the lack of structured emotional support available in traditional clinical settings. "We are teaching people how to set boundaries with their families, their employers, and even their own expectations."


Implications: A New Standard for Post-Cancer Life

The implications of this shift toward comprehensive survivorship care are far-reaching, affecting healthcare policy, workplace culture, and the fashion/wellness industries.

1. The Healthcare Landscape

The 2026 webinars signal a move toward a "Shared Care Model." In this model, the oncologist’s role diminishes after treatment, while the roles of physical therapists, mental health counselors, and survivorship advocates become central. This requires a shift in how healthcare is funded, moving away from a "treatment-only" reimbursement model toward one that covers long-term rehabilitation and emotional support.

2. Workplace Reintegration

As Beatty’s session will explore, the transition back to work is a major hurdle. The implications for HR departments are significant. Companies are increasingly being called upon to offer "phased returns" and to recognize that a survivor may have ongoing needs for physical therapy or mental health days. The "Root to Rise" focus on boundaries is essential for survivors who must navigate a professional world that expects them to "get back to normal" immediately.

3. The Travel and Lifestyle Industry

Pantelis’s inclusion of "travel considerations" highlights a niche but vital implication for the travel industry. Survivors with lymphedema risks require specific protocols during air travel (such as compression sleeves). As this demographic grows, we may see more specialized services and awareness within the hospitality and aviation sectors.

4. Redefining "Pink October"

Perhaps the most profound implication is the rebranding of Breast Cancer Awareness Month itself. For years, "Pink October" was criticized for "pink-washing"—focusing on marketing and "awareness" without addressing the gritty realities of the disease. By hosting sessions on scar management, lymphedema, and identity crises, organizations are moving toward a more authentic, substantive form of advocacy.

Conclusion: Rooting for a More Resilient Future

The "Living Well" and "Moving Emotions Forward" webinars represent a critical juncture in the story of breast cancer in the 21st century. They acknowledge that the "end" of cancer is rarely a clean break, but rather a messy, courageous transition into a new way of being.

By providing survivors with the data-backed tools to manage their physical scars and the emotional frameworks to rebuild their identities, experts like Voula Pantelis and Jacqueline Beatty are ensuring that the years added to a survivor’s life are lived with dignity, comfort, and purpose. As October 2026 approaches, the message is clear: survivorship is not just about staying alive—it is about the continuous, intentional act of rising.


Event Details:

  • Physical Effects Session: Thursday, October 15, 2026 | 1:00–2:00 p.m. ET
  • Emotional Transitions Session: Thursday, October 22, 2026 | 1:00–2:00 p.m. ET
  • Registration: Available through the Breast Cancer Canada portal and Rising Lotus official channels.

About the Author

Lina Irawan

Author

View All Posts

Post navigation

Previous: A New Frontier in Hepatology: FDA Greenlights GSK’s Hibsago as Potential ‘Functional Cure’ for Hepatitis B

Related Stories

a-new-horizon-in-womens-health-cakes-body-and-bcrf-announce-multi-year-commitment-to-younger-womens-breast-cancer-research
  • Patient Advocacy and Support

A New Horizon in Women’s Health: CAKES Body and BCRF Announce Multi-Year Commitment to Younger Women’s Breast Cancer Research

Iffa Jayyana October 21, 2026
a-global-beacon-for-the-forgotten-stage-325-landmarks-to-lightupmbc-for-metastatic-breast-cancer-awareness
  • Patient Advocacy and Support

A Global Beacon for the Forgotten Stage: 325 Landmarks to #LightUpMBC for Metastatic Breast Cancer Awareness

Neng Nana October 21, 2026
the-intersection-of-wellness-and-philanthropy-how-shop-pink-initiatives-are-fueling-the-next-generation-of-breast-cancer-breakthroughs
  • Patient Advocacy and Support

The Intersection of Wellness and Philanthropy: How "Shop Pink" Initiatives are Fueling the Next Generation of Breast Cancer Breakthroughs

Nana Wu October 21, 2026

Recent Posts

  • Beyond the Ribbon: Navigating the Complex Realities of Breast Cancer Survivorship
  • A New Frontier in Hepatology: FDA Greenlights GSK’s Hibsago as Potential ‘Functional Cure’ for Hepatitis B
  • The New Frontier: Roche and Hansoh Pharma’s $400M Strategic Alliance Signals Shift in Oncology R&D
  • A New Dawn for Reproductive Medicine: Eight Healthy Infants Born via Pioneering Mitochondrial Donation
  • Beyond the Mat: The Rise of Academic Yoga Studies in Higher Education

Recent Comments

No comments to show.

Archives

  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • September 2025
  • August 2025
  • July 2025

Categories

  • Breast Cancer Legislation and Policy
  • Breast Cancer Prevention and Lifestyle
  • Breast Cancer Surgery and Reconstruction
  • Chemotherapy and Targeted Therapy
  • Clinical Oncology Education
  • Clinical Radiology and Imaging
  • Genomics and Precision Medicine
  • Global Breast Cancer Awareness
  • Hormone Therapy and Endocrinology
  • Integrative Oncology and Holistic Care
  • Medical Research and Clinical Trials
  • Metastatic Breast Cancer Research
  • Patient Advocacy and Support
  • Psychosocial Support and Mental Health
  • Radiation Oncology
  • Survivorship and Post-Treatment
  • Treatment Innovations

You may have missed

beyond-the-ribbon-navigating-the-complex-realities-of-breast-cancer-survivorship
  • Patient Advocacy and Support

Beyond the Ribbon: Navigating the Complex Realities of Breast Cancer Survivorship

Lina Irawan October 21, 2026
a-new-frontier-in-hepatology-fda-greenlights-gsks-hibsago-as-potential-functional-cure-for-hepatitis-b
  • Treatment Innovations

A New Frontier in Hepatology: FDA Greenlights GSK’s Hibsago as Potential ‘Functional Cure’ for Hepatitis B

Asep Darmawan October 21, 2026
the-new-frontier-roche-and-hansoh-pharmas-400m-strategic-alliance-signals-shift-in-oncology-rd
  • Treatment Innovations

The New Frontier: Roche and Hansoh Pharma’s $400M Strategic Alliance Signals Shift in Oncology R&D

Nila Kartika Wati October 21, 2026
a-new-dawn-for-reproductive-medicine-eight-healthy-infants-born-via-pioneering-mitochondrial-donation-7
  • Genomics and Precision Medicine

A New Dawn for Reproductive Medicine: Eight Healthy Infants Born via Pioneering Mitochondrial Donation

Laily UPN October 21, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Copyright © All rights reserved. | MoreNews by AF themes.